PTCT- Ptc Therapeutics, Inc.

Name: Ptc Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 16 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Klein Matthew B.	394.1K	$32.36M	-
VP	Boulding Mark Elliott	113.7K	$9.34M	-10,462
CFO	Gravier Pierre	90.3K	$7.42M	-
Other	Pauwels Eric	80.1K	$6.58M	-
VP	Golden Lee Scott	79.1K	$6.50M	-

Activity

Buys and sells only

Transactions

10 filings · page 26

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jan 25, 2019	Schmertzler Michael	Director	Buy	66,225	$30.20	$1,999,995.00	+5.0%
Jan 7, 2019	Almstead Neil Gregory52	Chief Technical Ops Officer	Sell	653	$34.75	$22,691.75	-1.9%
Jan 7, 2019	Souza Marcio63	Chief Operating Officer	Sell	83	$34.75	$2,884.25	-2.9%
Jan 7, 2019	Utter Christine Marie58	Principal Financial Officer	Sell	297	$34.75	$10,320.75	-3.8%
Jan 7, 2019	Peltz Stuart Walter57	Chief Executive Officer	Sell	2,512	$34.75	$87,292.00	-4.0%
Jun 19, 2018	Almstead Neil Gregory52	EVP Research Pharma Ops &Tech	Sale+OE	20,000	$48.31	$966,240.00	-30.2%
Jun 1, 2018	Souza Marcio63	Chief Operating Officer	Sell	5,161	$34.65	$178,828.65	-7.6%
Jan 5, 2018	Almstead Neil Gregory52	EVP Research Pharma Ops &Tech	Sell	703	$18.03	$12,675.09	-3.1%
Jan 5, 2018	Peltz Stuart Walter57	Chief Executive Officer	Sell	2,230	$18.03	$40,206.90	-7.7%
Jan 4, 2018	Almstead Neil Gregory52	EVP Research Pharma Ops &Tech	Sell	77	$17.67	$1,360.59	-1.5%

← PrevPage 26Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC